Literature DB >> 6192681

The pharmacological profile of a substance P (SP) antagonist. Evidence for the existence of subpopulations of SP receptors.

S Rosell, U Björkroth, J C Xu, K Folkers.   

Abstract

The purpose of this study was to evaluate the pharmacological properties of a substance P (SP) analogue [D-Arg, D-Pro, D-Trp, Leu]SP as an SP antagonist. This analogue, blocked the SP-induced contractions of the isolated guinea-pig ileum and the rat urinary bladder and it exhibited no spasmogenic activity on these preparations. The affinity constant (pA2) for [D-Arg, D-Pro, D-Trp, Leu]SP versus SP was 6.31 on the guinea-pig ileum preparation and 5.30 on the rat urinary bladder preparation. The slopes of the regression lines of the Schild plots were close to unity. These data indicate that [D-Arg, D-Pro, D-Trp, Leu]SP blocks SP receptors in a simple competitive manner and suggest that there are at least two subpopulations of SP receptors. The contractions caused by the closely related tachykinins eledoisin and physalaemin were also blocked by the SP analogue. However, the slopes of the regression lines were significantly different from unity. Moreover, when tested on the hamster urinary bladder, which contracts at low concentrations of eledoisin but is rather insensitive to physalaemin and SP, [D-Arg, D-Pro, D-Trp, Leu]SP did not block the contractile actions of eledoisin or of physalaemin and SP. Compared to SP eledoisin and physalaemin may bind to SP receptors in a different manner. Eledoisin also seems to interact with receptors different from the SP receptors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6192681     DOI: 10.1111/j.1748-1716.1983.tb00019.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  26 in total

1.  Pharmacological properties of a potent and selective nonpeptide substance P antagonist.

Authors:  C Garret; A Carruette; V Fardin; S Moussaoui; J F Peyronel; J C Blanchard; P M Laduron
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

2.  In vivo and in vitro actions of mammalian tachykinins.

Authors:  U Holzer-Petsche; E Schimek; R Amann; F Lembeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-08       Impact factor: 3.000

3.  An examination of the pharmacology of two substance P antagonists and the evidence for tachykinin receptor subtypes.

Authors:  S J Bailey; R L Featherstone; C C Jordan; I K Morton
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

4.  Studies on effects of the substance P analogues [D-Pro2, D-Trp7,9]-substance P and [D-Arg1, D-Trp7,9, L-Leu11]-substance P not related to their antagonist action.

Authors:  F Lembeck; R Amann; L Barthó
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

5.  A comparison of the effects of three substance P antagonists on tachykinin-stimulated [3H]-acetylcholine release in the guinea-pig ileum.

Authors:  R L Featherstone; P Fosbraey; I K Morton
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

6.  Stimulation of afferent fibres of the guinea-pig ureter evokes potentials in inferior mesenteric ganglion neurones.

Authors:  R Amann; A Dray; M W Hankins
Journal:  J Physiol       Date:  1988-08       Impact factor: 5.182

7.  Receptors for neurotransmitters in opossum oesophagus muscularis mucosa.

Authors:  E E Daniel; J Jury; K H Robotham
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

8.  Comparison of cardiovascular and bronchoconstrictor effects of substance P, substance K and other tachykinins.

Authors:  X Hua; J M Lundberg; E Theodorsson-Norheim; E Brodin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-12       Impact factor: 3.000

9.  Involvement of substance P present in primary afferent neurones in modulation of cutaneous blood flow in the instep of rat hind paw.

Authors:  N Yonehara; J Q Chen; Y Imai; R Inoki
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

10.  Pharmacological characterization of a substance P antagonist, [D-Arg1,D-Pro2,D-Trp7,9,Leu11]-substance P.

Authors:  S P Watson
Journal:  Br J Pharmacol       Date:  1983-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.